Form 4 for TXG 10x Genomics, Inc.
Accepted 2023-03-16 00:00:00 ET · period of report 2023-03-14 · accession 0001567619-23-005183 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-16 | 2023-03-14 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $48.88 | -2,000 | 863.7K | -0.2% | -$97.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-14 | S | D | 303 | $49.28 | 863,405 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $49.15 to $49.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2023-03-14 | S | D | 1,697 | $48.81 | 863,708 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $48.15 to $49.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. (F3) Excludes 870 shares transferred to Sirius Trust, 6,050 shares transferred to Y/S Pot Trust and 37,390 shares transferred to the Y/S Descendants' Trust, on March 11, 2023. |